Texas allocates $50 million to UT-led IMPACT partnership for ibogaine clinical trials treating PTSD, addiction, and more.
A web of altered neurochemical pathways and physical brain changes result in post-traumatic stress disorder, or PTSD. The interplay between cortisol dysregulation, heightened norepinephrine levels, ...
Compass Pathways has navigated to another successful midphase readout, linking its psilocybin therapy and psychological support to improvements in post-traumatic stress disorder (PTSD) in a small ...
Many people have interpreted as a setback the “no” vote by an advisory committee to the Food and Drug Administration on Lykos Therapeutics’ new drug application for MDMA-assisted psychotherapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback